Integrated Approaches to close the loop in Type 1 diabetes. The RFA 08-012 emphasizes closing the loop in type 1 diabetes mellitus (T1DM), an endeavor that will depend on developing physiological models that will evaluate the reasons for glycemic variability using state of the art technologic approaches so that continuous subcutaneous insulin infusion (CSII) algorithms are better informed. The physiology studies need to be directed towards understanding the impact of variability introduced by circadian and intra-individual differences in post prandial insulin action, variability in the timing and rate of appearance of ingested carbohydrates into the systemic circulation and variability introduced by changes in physical activity. Using innovative specific activity clamps to minimize non steady state errors, we have recently developed and validated a triple tracer technique to measure post prandial peripheral and hepatic insulin action and rate of appearance of meal derived glucose. We have also developed and validated tools (eg., accelerometers, physical activity monitoring systems) to accurately capture daily physical activity. In this context, and utilizing the above techniques, the following specific aims will be addressed: 1) We will determine whether circadian pattern of post prandial insulin action and meal glucose appearance occurs in T1DM and the extent to which it differs from nondiabetic healthy subjects. We will also take this opportunity to further develop and validate a novel single tracer method to measure post prandial glucose kinetics. 2) We will explore if gastric emptying rate can predict post prandial meal glucose appearance, insulin action and 24 hour glucose variability in T1DM. To do so, we will screen for abnormalities in gastric emptying then use the tripe tracer method (or single tracer model if validated in aim 1) to determine if asymptomatic changes in gastric emptying are accompanied by changes in the timing and systemic rate appearance of ingested glucose and if so, the extent to which changes in the pattern of meal appearance predict post prandial hyperglycemia and glucose variability as measured using CGM parameters. This is an important variable to consider since abnormal gastric motility is frequently observed in asymptomatic individuals with T1DM. 3) We will evaluate the impact of low and moderate intensity physical activity on glucose variability, post prandial meal glucose appearance and insulin action in T1DM. To do so, we will assess the impact of low and moderate intensity exercise (measured by accelerometers) on glucose variability using CGM parameters (high and low blood glucose indices), meal glucose appearance and post prandial insulin action. We will take this opportunity to further modify tracer technique if necessary to clamp specific activity in order to accurately estimate insulin action in the post prandial state. Summary and Significance: Glucose variability and frequent hypoglycemia are major factors that limit optimal subcutaneous insulin delivery in T1DM. In this application, we propose to utilize and further innovate existing cutting edge techniques to develop a physiological model whereby daily variations in post prandial insulin action, gastric motility and physical activity captured with precise physical activity monitoring systems, e.g., accelerometers, are integrated to facilitate development of a model predictive control algorithm of individualized "closed loop system" of insulin delivery.

Public Health Relevance

The insulin pump and the glucose sensor have had limited impact on control of blood sugar and quality of life in type 1 diabetes mellitus (T1DM). This is because of limited knowledge of the effects of daily variation in efficiency of insulin action, stomach emptying capacity and physical activity on daily fluctuations in blood sugar in T1DM. Using innovative and cutting edge technologies, we will investigate the effects of all of these factors on sugar metabolism and fluctuations in blood sugar in people with T1DM on the insulin pump and glucose sensor and simultaneously initiate the use of new technology such as highly accurate accelerometers to capture physical activity. We believe that information obtained from our research will result in the development of a first generation endocrine artificial pancreas.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK085516-05
Application #
8537427
Study Section
Special Emphasis Panel (ZDK1-GRB-2 (O2))
Program Officer
Arreaza-Rubin, Guillermo
Project Start
2009-09-30
Project End
2014-08-31
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
5
Fiscal Year
2013
Total Cost
$717,961
Indirect Cost
$231,465
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Basu, Rita; Johnson, Matthew L; Kudva, Yogish C et al. (2014) Exercise, hypoglycemia, and type 1 diabetes. Diabetes Technol Ther 16:331-7
Hinshaw, Ling; Schiavon, Michele; Mallad, Ashwini et al. (2014) Effects of delayed gastric emptying on postprandial glucose kinetics, insulin sensitivity, and ?-cell function. Am J Physiol Endocrinol Metab 307:E494-502
Dube, S; Errazuriz, I; Cobelli, C et al. (2013) Assessment of insulin action on carbohydrate metabolism: physiological and non-physiological methods. Diabet Med 30:664-70
Carter, Rickey E; Shi, Qian (2013) Statistical evaluation of the use of concurrent controls in treatment screening studies. Clin Transl Sci 6:323-30
Hinshaw, Ling; Dalla Man, Chiara; Nandy, Debashis K et al. (2013) Diurnal pattern of insulin action in type 1 diabetes: implications for a closed-loop system. Diabetes 62:2223-9
Thatava, Tayaramma; Kudva, Yogish C; Edukulla, Ramakrishna et al. (2013) Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells. Mol Ther 21:228-39
Manohar, Chinmay; O'Keeffe, Derek T; Hinshaw, Ling et al. (2013) Comparison of physical activity sensors and heart rate monitoring for real-time activity detection in type 1 diabetes and control subjects. Diabetes Technol Ther 15:751-7
Basu, Ananda; Kudva, Yogish C; Basu, Rita (2013) GPR40 modulators: new kid on the block. Diabetes Care 36:185-7
Tonne, Jason M; Sakuma, Toshie; Deeds, Michael C et al. (2013) Global gene expression profiling of pancreatic islets in mice during streptozotocin-induced *-cell damage and pancreatic Glp-1 gene therapy. Dis Model Mech 6:1236-45
Scalzo, Patricia; Basu, Ananda; Kudva, Yogish (2013) Current state of diabetes technology clinics and programs in the United States. J Diabetes Sci Technol 7:798-9

Showing the most recent 10 out of 11 publications